Breaking News

European Commission Approves Roche’s Vabysmo for Wet AMD and DME
European Commission Approves Roche’s Vabysmo for Wet AMD and DME Sep 22, 2022 According to Roche, the European Commission (EC) has approved Vabysmo (faricimab) for the treatment of diabetic macular edema (DME) and wet age-relate
Trukera Medical Launches New ScoutPro Osmolarity System
Trukera Medical Launches New ScoutPro Osmolarity System Sep 13, 2022 Trukera Medical unveiled the first product under the new company name, the ScoutPro Osmolarity System. ScoutPro is the first and only portable osmomet

Industry News

Bausch + Lomb Forms Strategic Partnership With Munich Surgical Imaging GmbH
Bausch + Lomb Forms Strategic Partnership With Munich Surgical Imaging GmbH Aug 31, 2022 Bausch + Lomb has formed a strategic partnership with Munich Surgical Imaging GmbH (MSI)—a wholly‐owned subsidiary of Heidelberg Engineering GmbH.
Glaukos Licenses Iveena's Investigational Keratoconus Therapy
Glaukos Licenses Iveena's Investigational Keratoconus Therapy Aug 25, 2022 Glaukos announced that it obtained an exclusive global license to develop and market IVMED-80, an experimental pharmacologic therapy for keratoconus f

Popular

Treatment of Noninfectious Posterior Uveitis with Dexamethasone
Treatment of Noninfectious Posterior Uveitis with Dexamethasone Sep 26, 2022 Noninfectious uveitis involving the posterior segment is an important cause of vision loss. Oral corticosteroid therapy is the mainstay for initial tr
Simple 20-20-20 Screen Rule Really Does Help with Digital Eye Strain
Simple 20-20-20 Screen Rule Really Does Help with Digital Eye Strain Sep 26, 2022 20-20-20 screen rule has been suggested for a long time as a strategy to reduce eye strain while staring at a computer screen.

Editor's Pick

Compounded Medications in Ophthalmic Patient Care
Compounded Medications in Ophthalmic Patient Care Sep 26, 2022 Compounded medications may be used for a variety of reasons and they are an important source for otherwise unavailable medications—and for improving adherence, convenience, and affordability for patients.
CRISPR Genome Engineering for Retinal Diseases
CRISPR Genome Engineering for Retinal Diseases Sep 22, 2022 Novel gene therapy treatments for inherited retinal diseases have been at the forefront of translational medicine over the past couple of decades.
The Role of Gene Therapy in Inherited Retinal Disease Treatment
The Role of Gene Therapy in Inherited Retinal Disease Treatment Sep 20, 2022 In gene replacement therapy, a disease-causing gene is replaced with a functional copy of the gene.

ESCRS 2022

Interview: Co-Founder Morena Gomedi Unveils Details of Espansione Group’s Newest Technology
Interview: Co-Founder Morena Gomedi Unveils Details of Espansione Group’s Newest Technology Sep 21, 2022 Founded in 1981, Espansione Group designs and manufactures a wide range of innovative devices and solutions in the fields of ophthalmology and dermatology.
Several Satellite Symposia Planned for the 3rd Day of the ESCRS Congress
Several Satellite Symposia Planned for the 3rd Day of the ESCRS Congress Sep 18, 2022 The third day of the ESCRS Congress will be marked with several important satellite symposia, in which global eyecare companies will introduce case studies and clinical results of their newly-launched ophthalmic products with clinical experts.
2nd Day at ESCRS: Clinical Research Symposiums, Live Surgery Sessions And More
2nd Day at ESCRS: Clinical Research Symposiums, Live Surgery Sessions And More Sep 17, 2022 The second day of the ESCRS is going to be a day filled with many activities, such as live surgery sessions, courses and most importantly symposiums.
Ophthalmology Breaking News Subscribe